ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

CRGX CARGO Therapeutics Inc

15.43
-0.49 (-3.08%)
Jun 18 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 211,748
Bid Price 15.16
Ask Price 17.59
News -
Day High 16.15

Low
13.14

52 Week Range

High
33.92

Day Low 15.37
Share Name Share Symbol Market Stock Type
CARGO Therapeutics Inc CRGX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.49 -3.08% 15.43 16:44:38
Open Price Low Price High Price Close Price Previous Close
15.92 15.37 16.15 15.43 15.92
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
4,145 211,748 US$ 15.67 US$ 3,318,769 - 13.14 - 33.92
Last Trade Type Quantity Price Currency
18:40:57 2 US$ 15.21 USD

CARGO Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
635.38M 41.21M - 0 -98.15M -2.38 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

CARGO Therapeutics News

Date Time Source News Article
6/06/202415:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
6/04/202415:15Edgar (US Regulatory)Form 8-K - Current report
6/04/202415:05GlobeNewswire Inc.CARGO Therapeutics Adds Experienced Biopharma Executive to..
5/28/202407:14Edgar (US Regulatory)Form 8-K - Current report
5/28/202407:05GlobeNewswire Inc.CARGO Therapeutics to Participate in Upcoming Investor..
5/28/202407:00GlobeNewswire Inc.CARGO Therapeutics Announces $110.0 Million Private..
5/14/202415:18Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/14/202415:09Edgar (US Regulatory)Form 8-K - Current report
5/14/202415:05GlobeNewswire Inc.CARGO Therapeutics Reports First Quarter 2024 Financial..
4/15/202415:05GlobeNewswire Inc.CARGO Therapeutics Names Kapil Dhingra, M.B.B.S., to Board..
3/21/202415:05GlobeNewswire Inc.CARGO Therapeutics Reports Fourth Quarter and Full Year 2023..
3/08/202415:59Edgar (US Regulatory)Form 8-K - Current report
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No CRGX Message Board. Create One! See More Posts on CRGX Message Board See More Message Board Posts

Historical CRGX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week16.9718.4415.2216.83243,268-1.54-9.07%
1 Month20.2721.6915.2218.07202,461-4.84-23.88%
3 Months24.2326.6115.2219.57183,328-8.80-36.32%
6 Months18.3033.9215.2223.63240,499-2.87-15.68%
1 Year15.4533.9213.1422.29241,358-0.02-0.13%
3 Years15.4533.9213.1422.29241,358-0.02-0.13%
5 Years15.4533.9213.1422.29241,358-0.02-0.13%

CARGO Therapeutics Description

CARGO Therapeutics, Inc., a clinical-stage biotechnology company, develops chimeric antigen receptor (CAR) T-cell therapies for cancer patients. The company's lead program is CRG-022, an autologous CD22 CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in B-cell malignancies. It also develops CRG-023, a tri-specific CAR T product candidate that targets tumor cells with three B-cell antigen targets. The company was formerly known as Syncopation Life Sciences, Inc. and changed its name to CARGO Therapeutics, Inc. in September 2022. CARGO Therapeutics, Inc. was incorporated in 2019 and is headquartered in San Mateo, California.

Your Recent History

Delayed Upgrade Clock